# C1-A Evidence Manifest

**Manifest version:** 1.1  
**Repository:** `majidhussainqadri1-dot/cf-01-clinical-records-prescription-follow-up`  
**Branch:** `codex/cf-01-c1-a-foundation`  
**Manifest status:** public-safe governance evidence index; not legal, clinical, security, staging or production acceptance.

## 1. Evidence law

A committed manifest cannot truthfully certify its own final commit SHA: changing the manifest changes the branch head. Therefore this file does not present a self-referential branch SHA or workflow run as current acceptance evidence.

Exact immutable automated evidence must be established after the final content commit through all of the following:

1. the GitHub pull-request head SHA;
2. a successful exact-head workflow job that checks out that SHA explicitly;
3. a separate successful pull-request merge-ref compatibility job;
4. the final PR body recording the tested head, run ID, job results and scope;
5. GitHub's immutable check-run and workflow logs.

Any hard-coded SHA or run in an earlier revision of this document is historical only and must not be represented as the current validated baseline.

## 2. Truthful status

| Status class | Current evidence-backed state |
|---|---|
| Specified | Governing CF-01 plan, C1-A architecture/governance package and future-phase traceability exist |
| Public-safe C1-A governance source | Present on controlled branch |
| Automated QA | Must be read from the current PR exact-head and merge-ref checks; prior green runs are historical evidence only |
| Qualified legal/professional accepted | No |
| Companion contracts frozen | No |
| Clinical runtime coded under C1-A authority | No; prohibited |
| Installable clinical package authorized | No |
| Staging-Accepted | No |
| Live-Deployed | No |
| Operational | No |

Automated QA in this repository proves only the defined governance-document, public-safety, traceability, workflow-integrity and repository-policy assertions. It does not prove legal compliance, clinical correctness, production security, provider readiness, staging acceptance or runtime completion.

## 3. Evidence-package inventory

### Governing and control evidence

- `README.md` — canonical scope, activation law, phase model and truthful state.
- `CHANGE_CONTROL.md` — C1-A authorization and final review/merge-readiness authorization.
- `SECURITY.md` — public-repository disclosure and sensitive-artifact policy.
- `.github/workflows/governance.yml` — pinned exact-head and merge-ref automated gates.
- `.gitignore` — local/generated/sensitive-pattern exclusions.

### Architecture and governance evidence

- `docs/C1-A-FOUNDATION.md` — architecture, trust boundaries, data flow, roles, authorization, states and threat model.
- `docs/C1-A-CROSS-FILE-CONTRACTS.md` — owner boundaries and versioned assertion/event/query/command baseline.
- `docs/C1-A-CROSS-REPOSITORY-CONTRACT-TRACKING.md` — current native-owner issue, PR and freeze status.
- `docs/C1-A-LEGAL-PROFESSIONAL-APPLICABILITY-REGISTER.md` — qualified-review structure and launch gates.
- `docs/C1-A-RETENTION-LEGAL-HOLD-MATRIX.md` — record-category lifecycle, holds, disposal and backup reconciliation.
- `docs/C1-A-CRYPTOGRAPHY-STORAGE-ATTACHMENT-SECURITY.md` — keys, encryption, quarantine, scanning, delivery, recovery and provider exit.
- `docs/C1-A-OPERATIONAL-OWNERSHIP-AND-ESCALATION.md` — RACI, separation of duties, severity and escalation.
- `docs/C1-A-INDEPENDENT-REVIEW-PLAN.md` — legal, clinical, security, privacy, accessibility and resilience review plan.
- `docs/C1-A-REQUIREMENTS-TRACEABILITY.md` — C1-A requirements, owners, evidence and blocker state.
- `docs/C1-B-TO-C1-H-IMPLEMENTATION-TRACEABILITY.md` — CF01-FR-001–032 mappings, tests, migration, rollout and Definition of Done.
- `docs/C1-A-FINAL-REVIEW-CORRECTION-REGISTER.md` — final forensic findings, corrections and merge boundary.

### Automated control evidence

- `tools/validate_repository.py` — public-safety, governance-integrity, workflow and traceability validator.
- `tests/test_validate_repository.py` — adversarial negative fixtures for repository, path, workflow and mapping defects.

## 4. Automated control claims

The validator is intended to prove within its bounded scope that:

- every declared governance and evidence document is present and contains required semantic markers;
- CF01-FR-001 through CF01-FR-032 occur exactly once in structured future-phase table mappings;
- every C1-B through C1-H phase heading exists exactly once;
- sensitive/runtime/binary/data artifacts, symlinks, Git LFS and submodule indirection are rejected;
- generated, dependency, virtual-environment, build and artifact trees cannot hide files from inspection;
- composite and split sensitive-path variants are rejected;
- Python and shell tooling remain confined to approved governance-tool paths;
- workflow actions are pinned to exact commit SHAs;
- `pull_request_target`, floating runners and persisted checkout credentials are prohibited;
- exact-head and merge-ref compatibility are independently tested;
- whitespace integrity is checked.

A passing validator does not turn a documented future control into an operating production control.

## 5. Review-and-correction lineage

### Earlier foundation cycles

- corrected secret-scanner self-detection;
- blocked nested runtime, binary/office/archive/media artifacts and symlinks;
- corrected generated-bytecode false-positive ordering;
- blocked extensionless runtime, composite sensitive paths, Git LFS and submodule indirection;
- strengthened functional-requirement and phase-heading coverage.

### Final merge-readiness cycle — 05 August 2026

- removed stale self-referential evidence claims;
- made evidence manifest, cross-repository tracking and final review register mandatory;
- rejected duplicate requirement mappings;
- prohibited hidden generated/dependency trees;
- rejected split sensitive-path variants;
- pinned workflow actions and runner;
- separated exact-head from merge-ref validation;
- reconciled File 00 provider status after PR #13 merge;
- preserved all external C1-A exit blockers.

Full record: `docs/C1-A-FINAL-REVIEW-CORRECTION-REGISTER.md`.

## 6. Current cross-repository evidence boundary

As of 05 August 2026:

- File 00 provider PR #13 is merged to its native `main`;
- File 02 PR #4, File 08 PR #5 and File 09 PR #4 remain open and unmerged;
- File 08 base PR #3 and File 09 base PR #2 remain open;
- File 17, File 19, File 20, File 25 and File 24 contracts remain unimplemented;
- all nine native-owner tracking issues remain open;
- no contract meets the complete freeze criteria.

Merged provider code is not equivalent to a frozen CF-01 contract.

## 7. Remaining C1-A exit blockers

1. qualified Pakistan and target-jurisdiction legal/professional decisions;
2. approved category-specific retention durations/formulas and hold rules;
3. owner-frozen File 00/02/08/09/17/19/20/25/24 contracts and immutable-version consumer tests;
4. provider, region, key and storage selection with private architecture evidence;
5. BIA-approved RPO/RTO, key recovery, backup/restore and ransomware exercises;
6. named operational owners, deputies, coverage, training and conflict review;
7. independent assessor engagement, reports, remediation and retests;
8. staging, migration, rollback, browser/device/accessibility/load and clinical/patient UAT evidence;
9. Founder approval of the final C1-A package and explicit authorization to enter C1-B.

## 8. Phase-exit decision

**Governance PR repository merge-readiness:** determined only by the final corrected exact-head and merge-ref workflow results.  
**C1-A exit status:** `BLOCKED`.  
**C1-B runtime authorization:** `NOT GRANTED`.  
**Real patient-data authorization:** `NOT GRANTED`.

Merging PR #1 may establish the governance baseline on `main`; it cannot be interpreted as approval of any external blocker, runtime phase, patient-data processing or production claim.

## 9. Founder phase-exit approval record

| Field | Value |
|---|---|
| Evidence package version | Pending final C1-A external acceptance |
| Approved exact SHA | Pending |
| Decision | Pending |
| Conditions / time-bound risk acceptance | Pending |
| Approval date/time | Pending |
| Founder signature/reference | Pending |

No blank field and no repository merge may be interpreted as C1-A phase-exit approval.
